Anil Raghavan Appointed as Managing Director and CEO of Sun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company Limited (SPARC) has announced a significant change in its Board composition, appointing Mr. Anil Raghavan to the roles of Managing Director and Chief Executive Officer (CEO). This appointment comes as Dr. Rajamannar Thennati steps down from the Board upon completing his tenure.The company confirmed that Mr. Raghavan will assume the responsibilities starting August 11, 2026. He has been appointed as a director liable to retire by rotation, pending approval from members at the forthcoming 21st Annual General Meeting of the Company. Dr. Thennati's retirement is scheduled for August 10, 2026.
Mr. Raghavan, who currently serves as CEO of SPARC, is not related to any other director within the company.
Leadership Transition Details
The transition includes both appointments and retirements of key senior management personnel at Sun Pharma Advanced Research Company Limited. The following table outlines the details of these changes:| Particulars | Mr. Anil Raghavan | Dr. Rajamannar Thennati |
|---|---|---|
| Reason for Change | Appointment | Retirement |
| Date of Change / Term | August 11, 2026 | August 10, 2026 |
Profile Highlights
Mr. Anil Raghavan currently leads the company's strategic vision, working to realize SPARC’s goal of becoming a Global Pharmaceutical Leader with innovative solutions. He is based in the Mumbai office and also mentors AIRAMATRIX Private Limited, an early stage Machine Learning company that concentrates on applying high content image processing and deep learning methods to transform drug development and clinical practice. Mr. Raghavan has extensive experience, including time spent consulting with firms such as Arthur Andersen, KPMG, and Cambridge. He is an Industrial Engineer with a keen interest in the evolving science and technologies within pharmaceutical R&D and healthcare delivery segments.The company confirmed that Dr. Rajamannar Thennati's role transition details are not applicable as he is retiring.
SPARC Stock Price Movement
Today, shares of Sun Pharma Advanced Research Company Limited shed value, closing at ₹259.42 after slipping 1.78%. The stock traded within a range during the session, reaching a low of ₹258 and an intraday high of ₹269.39.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.